Hu-Lu-Ba-Wan Attenuates Diabetic Nephropathy in Type 2 Diabetic Rats through PKC-α/NADPH Oxidase Signaling Pathway

Table 3

The effect of HLBW on plasma lipid profiles in rats with DN.

Group	TG (mmol/L)	TC (mmol/L)	LDL-C (mmol/L)	HDL-C (mmol/L)
Control	1.04±0.16	2.09±0.29	0.51±0.15	1.50±0.24
Diabetic	3.48±1.14^△△	7.91±1.53^△△	4.46±1.57^△△	1.13±0.18
TFG	1.23±0.38^▴▴	4.73±0.74^▴▴	1.29±0.36^▴▴	1.40±0.36
PC	1.49±0.19^▴	5.06±1.05^▴	1.71±0.51^▴	1.35±0.35
HLBW	1.18±0.23^▴▴	4.33±0.59^▴▴	1.20±0.28^▴▴	1.46±0.29
Captopril	1.96±0.80	7.23±1.62	2.84±0.76	1.28±0.16

Values are mean ± SD (𝑁=8). ^△△𝑃<0.01 versus the control group, ^▴𝑃<0.05, ^▴▴𝑃<0.01 versus the untreated diabetic group. TG: triglyceride; TC: total cholesterol; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol.